BIO3 RES S R L has a total of 11 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are FIBROGEN INK, COHBAR INC and ONCLAVE THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Mexico | 2 | |
#5 | Argentina | 1 | |
#6 | Canada | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Bianchi Marco E | 4 |
#2 | Santangelo Francesco | 3 |
#3 | Degryse Bernard | 3 |
#4 | Scaffidi Paola | 2 |
#5 | Susanne Mueller | 2 |
#6 | Nigro Vincenzo | 2 |
#7 | Paola Scaffidi | 2 |
#8 | Bonaldi Tiziana | 2 |
#9 | Mueller Susanne | 2 |
#10 | Bernard Degryse | 2 |
Publication | Filing date | Title |
---|---|---|
CA2553679A1 | Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration | |
EP1696901A1 | The use of cystine or cysteine for the prevention and treatment of oxidative stress caused by haemodialysis in patients with chronic kidney diseases | |
AU2002217427A1 | Salts mixture for the preparation of pcr buffer solutions |